NSE filing, NSE: COSMOFIRST. Summary written from the filing by ALFA Finder's alert engine.
Cosmo First Ltd: key numbers
- Share price
- ₹766.70
- Market cap
- ₹2,013 Cr
- Revenue (annual)
- ₹3,639 Cr
- Net profit (annual)
- ₹156.0 Cr
- P/E (TTM)
- 12.1×Sector 45.1×
- Promoter holding
- 40.78%+0.00% QoQ
- FII holding
- 3.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cosmo First Ltd
All →Cosmo First Q2 FY27 Results: Net Profit ₹98.6 Cr, Up 111.1% YoY
Cosmo First Ltd reported revenue from operations of ₹1,388 Cr (+51.0% YoY) and net profit of ₹98.6 Cr (+111.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹98.6 Cr · +111.1% YoY
Cosmo First Board Meeting Date
COSMO FIRST Limited will hold a board meeting on 03-Nov-2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. Trading window closes from 01-Oct-2026 until 48 hours after results are published.
Cosmo First Acquisition Worth ₹6.1 Cr
Cosmo First Limited is acquiring Prolife Speciality Vet Clinic LLP for a cash consideration of ₹6.10 Crore to expand its Petcare division, Zigly.
- Value
- ₹6.10 Cr
Cosmo First Acquisition
Cosmo First Ltd will acquire Prolife Speciality Vet Clinic LLP in Mumbai via a slump sale to expand its petcare division. Consideration terms were not disclosed.
Cosmo First Earnings Call Transcript: Key Takeaways
Cosmo First reported strong Q1FY26 consolidated performance with 16% revenue growth and 38% EBITDA growth YoY, driven by higher volumes and cost rationalization.
- Call
- Guides 20% growth
Cosmo First Investor Presentation: Key Takeaways
Cosmo First delivered strong Q1 FY27 revenue growth of 46% YoY to ₹1,166 Cr, driven by specialty films, chemical growth, and consumer business scaling.
Other results update announcements
All →Awfis Space Solutions Results Update
Awfis reported Q2 FY27 normalised revenue up 26% to Rs 451 Crore; cash EBITDA rose 45% to Rs 49 Crore. Strong co-working and GCC demand drove growth.
Anthem Biosciences Results Update
Anthem Biosciences reported Q2 FY27 consolidated revenue of ₹5,940 Mn, up 7.9% year-on-year, and PAT of ₹2,115 Mn. H1 FY27 PAT rose 7.2% to ₹3,314 Mn.
Aayush Wellness Results Update
Aayush Wellness reported H1 FY27 consolidated total income of ₹7,061.82 lakhs, up 10.61%. PAT rose 5.86% to ₹250.10 lakhs.
Bata India Results Update
Bata India reported Q2 revenue of Rs. 8,618 million, up 7.5%, and PAT of Rs. 180 million, up 31%. Growth continued for a fourth consecutive quarter.
Asian Granito India Results Update
Asian Granito India's press release reports consolidated Q2 FY27 revenue up 18.8% to ₹528.5 Crore. Profit after tax fell to ₹5.22 Crore amid a sharp rise in power and fuel costs.
National Stock Exchange of India Results Update
NSE's press release reports Q2 FY27 consolidated PAT up 23% YoY to ₹2,578 crore. Total income rose 9% to ₹4,554 crore alongside the audited results.